Shanghai Runda Medical Technology (603108.SH) released an announcement, stating that the company plans to collaborate with Shanghai Zhikai Asset Management Co., Ltd. (abbreviated as "...")
According to the Zhitong Finance APP, Shanghai Runda Medical Technology (603108.SH) announced that the company plans to jointly invest with Shanghai Zhikai Asset Management Co., Ltd. (referred to as "Zhikai Asset"), Fuzhou Xintou Venture Capital Co., Ltd. (referred to as "Fuzhou Xintou"), Fujian Berry Health Genetic Technologies Co., Ltd. (referred to as "Fujian Berry"), and Shanghai Fukairuikang Enterprise Management Consulting Partnership (Limited Partnership) (referred to as "Shanghai Fukairuikang") to establish a partnership, primarily investing in projects in the healthcare sector. The investment target is named Fuzhou Xintou Zhikai Ruikang Venture Capital Fund Partnership (Limited Partnership). The total subscribed capital for this venture capital fund is 134 million yuan, of which the company, as a limited partner, subscribes for 26.8 million yuan, accounting for 20%.